Next-Generation Curcumin with Superior Bioavailability and Patented Matrix Technology

NovoCurmin®

NovoCurmin®, developed by İmuneks Farma, employs a matrix technology protected by multiple international patents that solves the solubility and bioavailability issues that have hampered the use of curcuminoids as an effective treatment agent. The patented technology only employs the U.S.A. FDA GRAS(Generally Recognized as Safe) and EFSA-approved food-grade excipients, to form a matrix with curcumin.

NovoCurmin® significantly enhances the solubility and bioavailability of turmeric extracts. Specifically, it achieves higher solubility and bioavailability compared to pythosomal and dextrin-based complexes.

NovoCurmin® represents a paradigm shift in curcumin supplementation, providing a higher Cmax and Auc, with efficient taste masking, for those seeking true curcumin benefits.

Key Facts
*These statements have not been evaluated by the US Food & Drug Administration or the European Food and Safety Authority. This product is not intended to diagnose, treat, cure, or prevent any disease.
Key Facts
*These statements have not been evaluated by the US Food & Drug Administration or the European Food and Safety Authority. This product is not intended to diagnose, treat, cure, or prevent any disease.
awards

Health Indications

Applications

We’ve unveiled the next application method for your product, tailored for optimal use.

NovoCurmin® offers superior curcumin absorption in a flexible, once-daily format, performing exceptionally both as a standalone and in synergistic combination formulations.

At Phytonet Pharmaceuticals, we specialize in providing a wide range of forms, ensuring versatility and quality in every solution we offer

phytonet favicon

Ready to realize your product’s full potential?

We work closely with our customers and our world-wide suppliers to source and scientifically back innovative ingredients for your product development needs.